| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 30-Sep-06 | | Total Revenue | 1,938 | 2,552 | 2,673 | | Cost of Revenue | 292 | 320 | 273 | | | Gross Profit | 1,646 | 2,232 | 2,401 | | | Operating Expenses | | Research Development | 31,716 | 24,236 | 21,294 | | Selling General and Administrative | 49,536 | 20,396 | 8,011 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (79,606) | (42,400) | (26,905) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,681 | 8,506 | 1,606 | | Earnings Before Interest And Taxes | (71,925) | (33,894) | (25,299) | | Interest Expense |
-
|
-
| 66 | | Income Before Tax | (71,925) | (33,894) | (25,365) | | Income Tax Expense | (278) |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (71,647) | (33,894) | (25,365) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (71,647) | (33,894) | (25,365) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($71,647) | ($33,894) | ($25,365) |
|
1.24% Nasdaq 
Income Statement
